Geron Corporation to Present at the Bank of America Healthcare Conference
Tuesday May 16, 7:30 am ET
MENLO PARK, Calif.--(BUSINESS WIRE)--May 16, 2006--Geron Corporation (Nasdaq:GERN - News) will present an update of the company's product development programs at noon PDT on Wednesday, May 17, 2006, at the Bank of America Healthcare Conference in Las Vegas.
ADVERTISEMENT
The update of Geron's portfolio of telomerase-based anti-cancer therapies will include information about GRN163L and GRNVAC1. The presentation will also include reviews of the company's human embryonic stem cell research in spinal cord injury (GRNOPC1), diabetes (GRNIPC1) and heart disease (GRNCM1). Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer, will deliver the presentation.
The audio and slide presentation will be available at the following Web site address: veracast.com. The replay will be available until June 2, 2006.
Geron is a Menlo Park, Calif.-based biopharmaceutical company developing and commercializing three groups of products: i) therapeutic products for oncology that target telomerase; ii) pharmaceuticals that activate telomerase in tissues impacted by senescence, injury or degenerative disease; and iii) cell-based therapies derived from its human embryonic stem cell platform for applications in multiple chronic diseases. For more information, visit www.geron.com. |
